Blood stasis removing pill for treating ankylosing spondylitis
What is Al technical title?
Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A technology of ankylosing spondylitis and Bitong Pills, which is applied in the field of Yuxue Bitong Pills, Chinese patent medicine for treating ankylosing spondylitis, pills), which can solve problems such as high risk, temporary cure, slow healing, etc.
Active Publication Date: 2013-01-02
郑州中医骨伤病医院
View PDF4 Cites 4 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
After the operation, the risk is high, the price is high, the patient is suffering, the healing is slow
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0058] The Yuxuebitong pill for treating ankylosing spondylitis of the present invention is represented by weight g (g), and the Yuxuebitong pill is composed of 48g of raw materials Panax notoginseng, 72g of angelica, 72g of salvia miltiorrhiza, 50g of safflower, and 50g of Clematis , Chuanxiong 48g, Corydalis 50g, Myrrh 45g, Turmeric 45g, Achyranthes bidentata 50g, Astragalus 60g, Cyperus 46g, Polygonum multiflorum 58g, peach kernel 42g, red peony root 45g, earthworm 42g, scorpion 16g, centipede 12g, mulberry Branch 50g and Wushao snake 32g are prepared.
Embodiment 2
[0060] The Yuxuebitong pill for treating ankylosing spondylitis of the present invention is represented by weight in g (g), and the Yuxuebitong pill is composed of 35g of raw materials Panax notoginseng, 65g of angelica, 60g of salvia miltiorrhiza, 40g of safflower, and 40g of Clematis , Chuanxiong 45g, Corydalis 40g, Myrrh 35g, Turmeric 35g, Achyranthes bidentata 40g, Astragalus 45g, Cyperus 35g, Polygonum multiflorum 45g, peach kernel 40g, red peony root 40g, earthworm 40g, scorpion 14g, centipede 10g, mulberry Branches 35g and black snake 30g are prepared.
Embodiment 3
[0062] The Yuxuebitong pill for treating ankylosing spondylitis of the present invention is represented by weight g (g), and the Yuxuebitong pill is composed of 55g of raw materials Sanqi, 80g of angelica, 80g of salvia miltiorrhiza, 55g of safflower, and 60g of Clematis , Chuanxiong 55g, Yanhusuo 60g, myrrh 55g, sliced turmeric 55g, Achyranthes bidentata 55g, astragalus 65g, vinegar cyperus 55g, Polygonum multiflorum 65g, peach kernel 50g, red peony root 55g, earthworm 50g, scorpion 28g, centipede 16g, mulberry Branch 55g and black snake 50g are prepared.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a blood stasis removing pill for treating ankylosing spondylitis. The blood stasis removing pill for treating ankylosing spondylitis is prepared by bulk pharmaceutical chemicals of 35-55 parts of notoginseng, 65-80 parts of angelica sinensis, 60-80 parts of salvia miltiorrhiza, 40-55 parts of flowers carthami, 40-60 parts of radix clematidis, 45-55 parts of ligusticum wallichii, 40-60 parts of rhizoma corydalis, 35-55 parts of myrrh, 35-55 parts of rhizoma wenyujin concisum, 40-55 parts of medicinal cyathula root, 45-65 parts of astragalus mongholicus, 35-55 parts of rhizoma cyperi, 45-65 parts of polygonum multiflorum, 40-50 parts of peach kernel, 40-55 parts of radix paeoniae rubra, 40-50 parts of lumbricus, 14-28 parts of scorpion, 10-16 parts of centipede, 35-55 parts of ramulus mori and 30-50 parts of zaocys dhumnade. The blood stasis removing pill for treating ankylosing spondylitis patients is remarkable in curing effect and has the effective rate as 93.8%.
Description
technical field [0001] The invention relates to the technical field of traditional Chinese medicine, in particular to a Yuxuebitong pill for treating ankylosing spondylitis (that is, a Chinese patent medicine for treating ankylosing spondylitis, the dosage form of which is a pill). Background technique [0002] Ankylosing spondylitis is a systemic, chronic, autoimmune disease of unknown etiology. Lesions primarily involve the sacrohip joints and spine, causing ankylosis and fibrosis. In most patients, the sacrohip joint is first affected, and then develops upward to the cervical spine, manifested as recurrent lumbosacral pain, low back pain, and a sense of stiffness, especially in the morning, limited lumbar mobility, late spine stiffness, and spinal kyphosis Deformity, some patients can affect the peripheral joints, affecting the hip joint can cause femoral head necrosis. The onset of this disease is hidden, the first symptoms are changeable, lack of specificity, it is ea...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more